 |
Prospector
Profile
3-29-001
|
| |
| Advanced Medical Optics, Inc. |
NAICS |
339112 |
| 1700 E. St. Andrew Place,
Santa Ana, CA 92705 |
Description |
Medical Instruments Mfg. |
| (714) 247-8200 |
Employees |
4100 |
| http://www.amo-inc.com |
Revenue |
(mil) |
1090.8500 |
| |
Income |
(mil) |
-192.9500 |
| |
Assets |
(mil) |
2748.3300 |
| |
Liability |
(mil) |
2149.6000 |
| |
(for the year ended 2007-12-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Advanced Medical Optics, Inc., incurred a net loss of $192 million on $1 billion of net sales for the year ended December 31, 2007, compared to earnings of $79 million on net sales of $997 million for the year ended December 31, 2006. The Company had total assets of $2.7 billion, total liabilities of $2.1 billion, and a stockholders' equity of $598 million at December 31, 2007, compared to total assets of $2 billion, total liabilities of $1.2 billion, and a stockholders' equity of $715 million at December 31, 2006.
|
| |
|
Intellectual Property:
The Company has rights to over 1,450 granted and issued patents and over 1,200 pending patent applications relating to aspects of the technology incorporated in many of its products. The Company owns or has rights to material trademarks or trade names used in conjunction with the sale of its products, which include Advanced Medical Optics(R), Advanced CustomVue(TM), AMO(R), Baerveldt(R), blink(TM), Blink-n-Clean(R), blink Contacts(R), ClariFlex(R), Complete(R), Consept(R), Consept 1 Step(R), CustomVue(R), ELLIPS(TM), Easy Rub(TM), Fusion(TM), Healon(R), Healon5(R), Healon D(TM), Healon GV(R), Intralase(R), iLASIK(TM), Occlusion Mode(R) , OptiBlue(TM), OptiEdge(TM), Oxysept(R), Oxysept 1 Step(TM), ReZoom(R), Sensar(R), Sovereign(R), Stabileyes(R), Star S4 IR(TM), Tecnis(R), The Unfolder(R), UltraCare(R), Ultrazyme(R), Verisyse(TM), VISX(R), WaveScan(R), WaveScan WaveFront(R), WhiteStar(R) and WhiteStar Signature(TM). [SEC Filing 10-K 03-03-08]
|
| |
|
Description:
Advanced Medical Optics, Inc., develops, manufactures and markets surgical devices for the eyes worldwide.
|
| |
|
Officers:
James V. Mazzo (Chair & CEO); Richard A. Meier (Pres. & COO); Robert F. Gallagher (SVP, Chief Acctg. Officer & Controller); Christopher G. Chavez (Dir.); Elizabeth H. Davila (Dir.); Daniel J. Heinrich (Dir.); William J. Link, Ph.D. (Dir.); G. Mason Morfit (Dir.); Michael A. Mussallem (Dir.)
|
| |
|
Auditor:
PricewaterhouseCoopers LLP
|
| |
|
Securities:
Common Stock Symbol EYE; NYSE;
60,691,764 common shares outstanding as of January 31, 2008.
|
| |
| |
| |
| return to main page |
|
|
